PPA
ZYNE

Parametric Portfolio Associates’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Parametric Portfolio Associates’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13,971
Closed -$54K – 4030
2020
Q1 		$54K Buy
+13,971
New +$64.9K ﹤0.01% 3829
2018
Q4 		– Sell
-10,549
Closed -$86K – 3977
2018
Q3 		$86K Sell
10,549
-12,296
-54% -$94.4K ﹤0.01% 3866
2018
Q2 		$223K Buy
22,845
+4,258
+23% +$43.6K ﹤0.01% 3667
2018
Q1 		$162K Buy
18,587
+185
+1% +$2K ﹤0.01% 3802
2017
Q4 		$230K Buy
+18,402
New +$211K ﹤0.01% 3701
2017
Q3 		– Sell
-13,121
Closed -$223K – 4059
2017
Q2 		$223K Buy
+13,121
New +$261K ﹤0.01% 3766

Other funds holding ZYNE

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $44.2M AUM 2.65% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return